HomeFile

File

TAVR in Low Risk Patients: 10 Year Evolution

The Treatment of severe aortic stenosis has experienced a significant revolution with TAVR, especially in high and...

Sub-Analysis of the REVIVED-BCIS2: Myocardial Viability Changes Prognosis in Ischemic Cardiomyopathy Revascularization?

The purpose of myocardial viability testing is to identify patients that might benefit from revascularization by diagnosing...

Preparation Before Elective Coronary Angiography: Is Prolonged Fasting the Only Option?

When scheduling a coronary angiography, patients are usually instructed to fast for at least 8 hours (no oral...

Contemporary Outcomes of CTO PCI in Europe: The ERCTO Registry

Roughly 20% or coronary angiographies show some form of chronic total occlusion (CTO), and this figure is...

Should We Treat Obstructive Coronary Artery Disease in TAVI?

Coronary artery disease, both obstructive and non-obstructive, often coexists with significant aortic stenosis. Therapeutic decision-making in this scenario...

Left Atrial Appendage Closure and Concomitant Transcatheter Intervention: Can We?

Several scientific societies support performing left atrial appendage occlusion (LAAO) as a stand-alone procedure, even though it...

Benefit of Cusp overlap method for self‐expanding transcatheter aortic valves

The need for permanent pacemaker implantation (PPM) continues to be one of the main challenges in TAVR,...

Does Post-Dilation in TAVR Affect its Long-Term Outcomes?

Transcatheter aortic valve replacement (TAVR) has widely demonstrated its significant benefits, both in high-risk and inoperable patients,...